Information Technology
2022
Buy Side M&A Advisory

Argos Wityu acquired a majority stake in SB Italia

About the Transaction

Buy-side advisors to the European PE firm, Argos Wityu, advised on the acquisition of a majority stake in SB Italia, a system integrator and software company.

GC Advisory: 

  • originated the opportunity to Argos 
  • worked closely with SBI and Argos’ teams to provide both parties with M&A advice and support in drafting the transaction documentation, facilitated the negotiation
Results
+ €
30
M

revenues

+ €
5
M

EBITDA

12
+

months

Jean Pierre di Benedetto
Managing partner Argos Wityu

"SB Italia is a clear example of Italian entrepreneurial excellence, founded in 2004 by the current CEO, Massimo Missaglia. Under his leadership, the company has grown from being a small entity with a turnover of 1 million euros to over 40 million in 2023. Today, SB Italia S.r.l. is one of the reference points in the Italian IT landscape, capable of enabling new business models, optimizing day-to-day management, and rationalizing the IT expenditure of its clients, guiding them through the process of Digital Transformation”

Deal team

Giovanni Caroli
Partner, Co-Founder​
Francesco Parisi
Senior Associate
Meet the team
About the Financial Partner

GC Advisory, Boston Consulting Group, PWC, CBA, Gartner e Giovannelli & Associati

Recent transactions

2025
Sell Side M&A Advisory

acquired a majority stake in

Agren, an Italian agrisolar (agrivoltaic) project company sponsored by Di Carlo Holding (DCH), has completed a €132 million senior secured bond facility fully subscribed by Pollen Street Capital. The proceeds will finance the development of a 14-plant agrivoltaic portfolio located in Puglia and Campania, with an aggregate installed capacity of around 139 MW, supporting DCH’s build-out of the Agren platform in Italy’s fast-growing agrivoltaics segment

2025
Sell Side M&A Advisory

acquired a majority stake in ​

Else Solutions S.r.l., an Italy-based company specialized in the distribution and production of advanced solutions for nuclear medicine and radiotherapy, has sold a majority stake to 21 Invest through its impact fund 21 Invest Healthcare. The transaction also saw the participation of BNP Paribas BNL Equity Investments and Fondo Italiano di Investimento as co-investors, with Banco BPM providing acquisition financing and operational credit lines to support the company’s next growth phase.

All transactions